RSSCategory: Standards and Guidelines

PathXL Granted Patent for Automated Tumor Analysis on H&E Digital Slides

| March 3, 2016 | 0 Comments

Congratulations to Dr. Hamilton and the team at PathXL on this patent.  Look for more patents to be granted to PathXL in the future.  There is a perfect storm brewing right now in digital pathology — goals for precision medicine, image analysis/analytics/algorithms for best clinical practices and a recognition that computer technologies will be required to […]

Continue Reading

Omnyx Applauds FDA and Digital Pathology Association on Recent Collaboration 

| January 17, 2016 | 0 Comments

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been classified, and for which there is no predicate device (as in whole slide imaging systems). If the FDA […]

Continue Reading

College of American Pathologists Notably Absent from Choosing Wisely

| November 22, 2015 | 2 Comments

I recalled sharing news a couple of years ago about ASCP and the ABIM Foundation partnering together for something called “Choosing Wisely” and thought I would check in to see what this site consisted of now. I think the addition of information for patients is somewhat new in addition to information for clinicians. According the […]

Continue Reading

“Herceptoid” and “Personalized” Medicine

| September 30, 2015 | 0 Comments

Over the summer a longtime friend asked if I could review some slides for a friend of his, or actually from his friend’s wife. Of course I agreed to do so. He mentioned that she had “metastatic breast cancer” and wanted to make sure the slides fit that diagnosis to insure she was getting the […]

Continue Reading

Digital Pathology Story Appears in Wall Street Journal

| June 9, 2015 | 1 Comment

Facebook and a number of folks last night during a bad time for the Chicago Blackhawks made me aware of a piece by Ms. Landro at the Wall Street Journal that touches on a number of issues including mention of use of digital pathology for image analysis as illustrated by work being done at UPMC with […]

Continue Reading

Group releases guidelines that seek to reduce unnecessary cervical cancer screening

The NPR (5/1, Haelle) “Shots” blog reports that yesterday, the American College of Physicians released guidelines “that aim to reduce unnecessary” cervical cancer “screening. They say that no women should be getting annual Pap tests, at any age.” The blog adds that “the ACP also has a preference for co-testing — Pap plus HPV test — for women age 30 […]

Continue Reading

CAP and NSH Release New Guideline to Improve Patient Safety

| April 24, 2015 | 0 Comments

Pathologists and histotechnologists team to provide recommendations to standardize block and slide labeling practices Recently the College of American Pathologists (CAP) and the National Society for Histotechnology (NSH) released the first evidence-based guideline to ensure patient safety through the uniform labeling of paraffin blocks and slides. The guideline, “Uniform Labeling of Blocks and Slides in Surgical […]

Continue Reading

CAP eFRM named MEDITECH’s Recommended Solution for Synoptic Reporting in Pathology

| April 13, 2015 | 0 Comments

Boston, MA – After cementing interface protocols for a seamless integration, the College of American Pathologists’ electronic Forms and Reporting Module (CAP eFRM) is MEDITECH’s recommended synoptic reporting solution for pathology. CAP eFRM ensures that pathologists will remain compliant with American College of Surgeons (ACoS) and CAP requirements for synoptic cancer reporting. Developed in partnership between […]

Continue Reading

Accuracy of HER2 Testing in Gastric Cancer

| April 5, 2015 | 0 Comments

With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab (Herceptin) for gastric and gastro-oesophageal (G/GEJ) patients who are over-expressing HER2. In 2010, the FDA approved Trastuzumab for treatment of […]

Continue Reading

Thoughts on Recent JAMA Breast Biopsy Study

| March 30, 2015 | 0 Comments

The accuracy of pathology diagnoses of breast biopsy results was recently called into question in the study published in the March 17, 2015, issue of the Journal of the American Medical Association (JAMA). Researchers reported that practicing pathologists incorrectly diagnosed nearly 25% of breast biopsies presented to them in a test study. These findings did […]

Continue Reading

Pathology Plays a Central Role in the Era of Personalized Medicine

| February 2, 2015 | 0 Comments

Originally published on KevinMD.com by Dr. Michael Misialek, a practicing pathologist in Massachusetts.   As a pathologist, I recognize the importance of every diagnosis. Behind each slide is a patient, a family, a network of family and friends. A string of dominoes that is set into motion with my diagnosis. All treatment begins with a diagnosis. […]

Continue Reading

Applied Spectral Imaging receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

| January 22, 2015 | 0 Comments

Carlsbad, CA. – January 21, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis platform. ASI’s GenASIs HiPath IHC Family is an advanced image analysis platform for IHC and CISH samples that integrates with existing lab […]

Continue Reading

TRIBVN Digital Pathology Solutions Receive Health Canada Clearance

| January 20, 2015 | 0 Comments

Châtillon, France – Tuesday, January 20th 2015 – TRIBVN, the European leading provider of medical imaging solutions for laboratory, announced today that its two Digital Pathology software solutions CaloPix and TeleSlide have obtained a Health Canada Class II Medical Device License. CaloPix and TeleSlide are software solutions for managing, viewing, analyzing and sharing all the images produced in the […]

Continue Reading

Facebook for Pathology Consultations: We Can but Should We?

| January 12, 2015 | 0 Comments

Everyday in dozens of groups on Facebook pathologists from all over the world post images of pathology cases with brief clinical histories, gross descriptions and/or IHC or other ancillary test information for a couple of purposes. One is to case share with other members in the group, sharing their diagnosis, opinions on the case and making […]

Continue Reading